Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.
2.

Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.

Dominguez-Gutierrez PR, Ceribelli A, Satoh M, Sobel ES, Reeves WH, Chan EK.

Arthritis Res Ther. 2014 Jan 24;16(1):R23. doi: 10.1186/ar4451.

3.

Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosus.

Dominguez-Gutierrez PR, Ceribelli A, Satoh M, Sobel ES, Reeves WH, Chan EK.

J Clin Immunol. 2014 Feb;34(2):171-80. doi: 10.1007/s10875-013-9973-3. Epub 2013 Dec 1.

4.

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.

Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK, Behrens TW, Baechler EC.

Arthritis Rheum. 2009 Oct;60(10):3098-107. doi: 10.1002/art.24803.

5.
6.

MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N.

Arthritis Rheum. 2009 Apr;60(4):1065-75. doi: 10.1002/art.24436.

7.

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.

Willis R, Seif AM, McGwin G Jr, Martinez-Martinez LA, González EB, Dang N, Papalardo E, Liu J, Vilá LM, Reveille JD, Alarcón GS, Pierangeli SS.

Lupus. 2012 Jul;21(8):830-5. doi: 10.1177/0961203312437270. Epub 2012 Feb 17.

8.

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P.

Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2. Review.

PMID:
24189283
9.

Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus.

Li J, Zhao S, Yi M, Hu X, Li J, Xie H, Zhu W, Chen M.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Feb;36(2):109-15. doi: 10.3969/j.issn.1672-7347.2011.02.003.

10.

Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.

Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.

Arthritis Rheum. 2009 May;60(5):1463-71. doi: 10.1002/art.24449.

11.

Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia.

Gu D, Chen Z, Zhao H, Du W, Xue F, Ge J, Sui T, Wu H, Liu B, Lu S, Zhang L, Yang R.

Hum Immunol. 2010 Jun;71(6):586-91. doi: 10.1016/j.humimm.2010.02.010. Epub 2010 Mar 7.

PMID:
20153790
12.

Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.

Feng X, Li R, Huang J, Zhang H, Zhu L, Hua B, Tsao BP, Sun L.

Arthritis Res Ther. 2010;12(2):R59. doi: 10.1186/ar2972. Epub 2010 Apr 1.

13.

Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis.

Lu MC, Lai NS, Chen HC, Yu HC, Huang KY, Tung CH, Huang HB, Yu CL.

Clin Exp Immunol. 2013 Jan;171(1):91-9. doi: 10.1111/j.1365-2249.2012.04676.x.

14.

Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus.

Carvalheiro T, Rodrigues A, Lopes A, Inês L, Velada I, Ribeiro A, Martinho A, Silva JA, Pais ML, Paiva A.

Clin Dev Immunol. 2012;2012:934161. doi: 10.1155/2012/934161. Epub 2012 Aug 30.

15.

Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.

Narumi S, Takeuchi T, Kobayashi Y, Konishi K.

Cytokine. 2000 Oct;12(10):1561-5.

PMID:
11023674
16.

Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.

Antonelli A, Fallahi P, Ferrari SM, Corrado A, Sebastiani M, Giuggioli D, Miccoli M, Zignego AL, Sansonno D, Marchi S, Ferri C.

Clin Rheumatol. 2013 Aug;32(8):1147-54. doi: 10.1007/s10067-013-2246-y. Epub 2013 Apr 5.

PMID:
23559389
17.

Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.

Antonelli A, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Di Domenicantonio A, Ferri C.

J Rheumatol. 2012 May;39(5):979-85. doi: 10.3899/jrheum.111132. Epub 2012 Mar 15.

PMID:
22422499
18.

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.

Fu Q, Chen X, Cui H, Guo Y, Chen J, Shen N, Bao C.

Arthritis Res Ther. 2008;10(5):R112. doi: 10.1186/ar2510. Epub 2008 Sep 15.

19.

The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.

Ambrose N, Khan E, Ravindran R, Lightstone L, Abraham S, Botto M, Johns M, Haskard DO.

Clin Exp Immunol. 2015 Sep;181(3):427-33. doi: 10.1111/cei.12655. Epub 2015 Jul 14.

20.

Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.

Choe JY, Kim SK.

Inflamm Res. 2016 Jun;65(6):479-88. doi: 10.1007/s00011-016-0930-5. Epub 2016 Feb 26.

PMID:
26921306

Supplemental Content

Support Center